CytomX Therapeutics (CTMX) Assets (2014 - 2026)
CytomX Therapeutics' Assets came in at $381.23 million for Q2 2026, up 117.8% from $175.06 million a year earlier and up 6.1% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, CytomX Therapeutics' Assets was $151.57 million, up 25.7% from FY2024.
- Assets carries a five-year compound annual growth rate of -15.8% (FY2020 to FY2025).
- Going back by year, Assets was $120.53 million in FY2024 (-40.3%), $201.79 million in FY2023 (-22.7%), $260.89 million in FY2022 (-23.1%) and $339.41 million in FY2021 (-5.4%).
- The Q2 2026 figure represents the highest quarterly Assets since Q2 2021.
- Year-over-year, Assets has increased for five consecutive quarters, with growth averaging 38.5% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q1 2026 (growth of 264.8%), and the weakest in Q1 2025 (a decline of 46.7%).
- Business Quant data shows CTMX's Assets at $359.36 million (Q1 2026), $151.57 million (Q4 2025) and $158.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | CytomX Therapeutics | 586.15 Mn | -371.52 Mn | - | 381.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 381.23 Mn |
| Mar 31, 2026 | 359.36 Mn |
| Dec 31, 2025 | 151.57 Mn |
| Sep 30, 2025 | 158.25 Mn |
| Jun 30, 2025 | 175.06 Mn |
| Mar 31, 2025 | 98.50 Mn |
| Dec 31, 2024 | 120.53 Mn |
| Sep 30, 2024 | 138.98 Mn |
| Jun 30, 2024 | 159.22 Mn |
| Mar 31, 2024 | 184.69 Mn |
| Dec 31, 2023 | 201.79 Mn |
| Sep 30, 2023 | 221.17 Mn |
| Jun 30, 2023 | 209.19 Mn |
| Mar 31, 2023 | 234.63 Mn |
| Dec 31, 2022 | 260.89 Mn |
| Sep 30, 2022 | 226.49 Mn |
| Jun 30, 2022 | 260.09 Mn |
| Mar 31, 2022 | 296.83 Mn |
| Dec 31, 2021 | 339.41 Mn |
| Sep 30, 2021 | 371.23 Mn |
API Access
CytomX Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();